# Hour 01: 01:00-01:59 - Overnight Low Volume Operations

Released on 23 March 2026 | CEO Kevin Kawchak | ChemicalQDevice

## Hour Summary

Hour 01 continues the overnight low-volume period of the 24-hour on-demand
simulation cycle. One new emergency imaging patient arrives at 01:22 for
assessment of liver metastases. One patient (PAT-ODMND-0002) is discharged
at 01:05 following completion of her imaging procedure in the prior hour.
Two overnight patients continue recovery and monitoring.

## Site Status at 01:00

- Total patients on-site: 4 (PAT-ODMND-0002 pending discharge, PAT-ODMND-0003
  recovery, PAT-ODMND-0005 pediatric overnight, no active procedures)
- Active procedures: 0
- Robots in active mode: 1 (COMPN-03 passive monitoring)
- Robots in standby mode: 28
- Robots in maintenance: 0
- Queue length: 0 across all stations
- Site safety officer on duty: SSO-N1 (night shift)

## New Patient Arrivals

| Patient ID | Time | Age | Sex | Cancer Type | Stage | ECOG | Robot Needed |
|-----------|------|-----|-----|-------------|-------|------|-------------|
| PAT-ODMND-0006 | 01:22 | 45 | M | Liver metastases (colorectal primary) | IV | 1 | Imaging (8) |

Patient PAT-ODMND-0006 is a 45-year-old male with Stage IV colorectal cancer
with liver metastases presenting for emergency overnight imaging assessment.
He was referred by his oncologist for urgent evaluation of new hepatic lesions
identified on recent bloodwork showing elevated CEA and liver function markers.
ECOG performance status 1. Assessment plan: robotic CT-enhanced liver imaging
to characterize metastatic burden for multidisciplinary tumor board review.

## Overnight Recovery Patients (Continuing)

| Patient ID | Age | Sex | Cancer Type | Status | Since |
|-----------|-----|-----|-------------|--------|-------|
| PAT-ODMND-0003 | 61 | M | Mediastinal tumor | Post-surgical recovery | 22:30 prior day |
| PAT-ODMND-0005 | 8 | M | Pediatric ALL | Overnight companion monitoring | 21:00 prior day |

## Active Procedures This Hour

### Imaging Assessment (01:28-01:48)
- Patient: PAT-ODMND-0006
- Robot: IMAGE-03 (Imaging Assistant, Instance 3)
- Bay: Imaging Bay 3
- Procedure: CT-enhanced liver metastasis characterization
- Duration: 20 minutes (setup 3 min, scan 15 min, post-processing 2 min)
- Scan coverage: 96% of hepatic volume
- Image quality score: 8.5/10
- Lesion detection: 3 hepatic metastases identified
  - Segment VI: 22 x 18 mm
  - Segment VII: 15 x 12 mm
  - Segment IV: 8 x 6 mm (new, not previously documented)
- Motion artifact count: 1 (minor, auto-compensated)
- Outcome: Successful. Images uploaded to DICOM server for tumor board review
  and digital twin initialization.

Minute-by-minute summary (active procedure):
- 01:28 - Patient positioned supine, contrast access confirmed
- 01:29 - IMAGE-03 calibration and scan planning complete
- 01:30 - Initial scout scan, breathing instructions given
- 01:31 - Arterial phase acquisition initiated
- 01:34 - Arterial phase complete, portal venous phase initiated
- 01:38 - Portal venous phase complete, delayed phase initiated
- 01:41 - Delayed phase complete, AI reconstruction initiated
- 01:43 - 3D liver segmentation complete, metastases auto-detected
- 01:45 - Lesion measurements confirmed by AI model
- 01:46 - Final image quality review passed
- 01:47 - Patient assisted off table, post-procedure vitals taken
- 01:48 - Scan complete, images uploaded, patient to observation

## Patient Departures This Hour

| Patient ID | Time | Outcome | Notes |
|-----------|------|---------|-------|
| PAT-ODMND-0002 | 01:05 | Discharged | Post-imaging observation complete, HCC imaging results uploaded |

## Adverse Events

None this hour.

## Investigational Drug Administrations

None this hour.

## Site Utilization

- Overall robot utilization: ~3% (IMAGE-03 active for 20 min, COMPN-03
  passive monitoring throughout)
- Queue lengths: 0 across all stations
- Average wait time: 6 minutes (PAT-ODMND-0006: 01:22 arrival to 01:28 scan)
- Robot cleaning cycles: 1 (IMAGE-03 post-procedure)

## Regulatory Compliance Notes

### ICH E6(R3) - Adaption
- Section 1.1.1: All procedures conducted in accordance with ethical principles
  and applicable GCP requirements. Emergency overnight imaging maintained
  identical safety standards to daytime operations.
- Section 2.9.1: Complete audit trail maintained for IMAGE-03 imaging session
  including scan parameters, acquisition timestamps, and lesion detection logs.
- Section 4.2.1: Data capture for CT imaging session included probe positioning,
  contrast timing, image quality metrics, and lesion measurements with
  synchronized UTC timestamps.

### 21 CFR Part 50 - Adaption
- Section 50.25: Patient PAT-ODMND-0006 completed informed consent including
  Physical AI system disclosure, USL readiness scores, and right to
  non-Physical AI alternatives prior to imaging procedure.
- Section 50.30: Pre-procedure safety matrix completed: authorization verified,
  patient identity confirmed, clinical data accessed via FHIR, robot readiness
  confirmed, environmental checks passed.

### 21 CFR Part 312 - Adaption
- Section 312.62: Investigator recordkeeping maintained for all overnight
  patients including Physical AI system interaction logs and vital sign records.
- Section 312.32: Safety reporting systems active and monitoring all patients.
  No reportable events this hour.

## Complementary Framework References

The Unification Standard Level (USL) framework (Kawchak, 2026;
DOI: 10.5281/zenodo.18778220) provides complementary robot technical
interoperability scoring. Imaging Assistant Robot IMAGE-03 operates on a
platform evaluated at USL scores consistent with the Advanced band,
reflecting strong sensor integration and AI-driven image acquisition.
See physical-ai-oncology-trials/unification/usl/paper/usl_oncology_trials.tex.

The single-patient cancer journey framework (Kawchak, 2026;
DOI: 10.5281/zenodo.19119939) demonstrated autonomous Physical AI trial
orchestration for an individual patient. PAT-ODMND-0006's emergency imaging
assessment represents Stage 3-equivalent diagnostic evaluation within a
multi-patient, multi-cancer-type, on-demand operational context.
See physical-ai-oncology-trials/patient-journey/paper/patient_journey_paper.tex.
